Kapferer-Seebacher, Ines http://orcid.org/0000-0001-6169-6812
Waisfisz, Quinten
Boesch, Sylvia
Bronk, Marieke
van Tintelen, Peter
Gizewski, Elke R.
Groebner, Rebekka
Zschocke, Johannes
van der Knaap, Marjo S.
Funding for this research was provided by:
Austrian Science Fund (I 2909-B30)
Dutch ZonMw TOP (91211005)
Article History
Received: 5 October 2018
Accepted: 29 November 2018
First Online: 8 December 2018
Compliance with ethical standards
: The study was conducted with the probands’ understanding and full written consent as part of the Biobank for Rare Diseases and the pilot study MRI in rare neurologic diseases, both approved by the Ethics Committee of the Medical University Innsbruck, Austria (study nos. UN4501 and 1074/2017); the study was also approved by the Ethics Committee for gene identification research on patients with unclassified leukoencephalopathies at the VU University Medical Center Amsterdam (2010/267), in accordance with the Declaration of Helsinki of 1975 as revised in 2013.
: The authors report no disclosures relevant to the manuscript.